Author:
Saharkhiz Niloufar,Ha Richard,Taback Bret,Li Xiaoyue Judy,Weber Rachel,Nabavizadeh Alireza,Lee Stephen A.,Hibshoosh Hanina,Gatti Vittorio,Kamimura Hermes A. S.,Konofagou Elisa E.
Abstract
AbstractNon-invasive diagnosis of breast cancer is still challenging due to the low specificity of the imaging modalities that calls for unnecessary biopsies. The diagnostic accuracy can be improved by assessing the breast tissue mechanical properties associated with pathological changes. Harmonic motion imaging (HMI) is an elasticity imaging technique that uses acoustic radiation force to evaluate the localized mechanical properties of the underlying tissue. Herein, we studied the in vivo feasibility of a clinical HMI system to differentiate breast tumors based on their relative HMI displacements, in human subjects. We performed HMI scans in 10 female subjects with breast masses: five benign and five malignant masses. Results revealed that both benign and malignant masses were stiffer than the surrounding tissues. However, malignant tumors underwent lower mean HMI displacement (1.1 ± 0.5 µm) compared to benign tumors (3.6 ± 1.5 µm) and the adjacent non-cancerous tissue (6.4 ± 2.5 µm), which allowed to differentiate between tumor types. Additionally, the excised breast specimens of the same patients (n = 5) were imaged post-surgically, where there was an excellent agreement between the in vivo and ex vivo findings, confirmed with histology. Higher displacement contrast between cancerous and non-cancerous tissue was found ex vivo, potentially due to the lower nonlinearity in the elastic properties of ex vivo tissue. This preliminary study lays the foundation for the potential complementary application of HMI in clinical practice in conjunction with the B-mode to classify suspicious breast masses.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference66 articles.
1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA. Cancer J. Clin. 69, 7–34 (2019).
2. Etzioni, R. et al. The case for early detection. Nat. Rev. Cancer 3, 243–252 (2003).
3. Shapiro, S., Venet, W., Strax, P., Venet, L. & Roeser, R. Ten- to fourteen-year effect of screening on breast cancer mortality. J. Natl. Cancer Inst. 69, 349–355 (1982).
4. Tabár, L. et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the breast cancer screening working group of the Swedish National Board of Health and Welfare. Lancet (London, England) 1, 829–832 (1985).
5. Kolb, T. M., Lichy, J. & Newhouse, J. H. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225, 165–175 (2002).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献